U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. Focus Areas of Regulatory Science Report
  6. Physical Standards and Reference Materials
  1. Focus Areas of Regulatory Science Report

Physical Standards and Reference Materials

Medical science professionals working in a laboratory.

Physical standards and reference materials are substances or materials produced in a controlled environment that are used as a “calibrator” to produce additional substances or materials (e.g., materials of documented purity certified by an analytical laboratory or other noncommercial establishment). FDA scientists may develop standards and reference materials and may depend on internal or external lab consortia for validation and distribution. In addition, external parties (e.g., U.S. National Institute of Standards and Technology and National Institute of Biological Standards and Control in the United Kingdom) develop standards and reference materials and depend on FDA laboratories to participate in validation studies. For example, annually, FDA develops, validates, and distributes the strain-matched standard of the seasonal and pandemic strains of the influenza vaccine for potency (effectiveness) testing. The Agency also participates in developing standards for a variety of regulated products that are often later adopted as international standards by the World Health Organization (WHO). Currently, FDA laboratories are involved in an international multi-laboratory study endorsed by WHO to validate reference materials for SARS-CoV-2 ribonucleic acid (RNA) and antibody detection assays. Some of FDA’s laboratories also function as a WHO Collaborating Center.

Another example where FDA facilitates product development through references is the FDA-ARGOS database which provides reference-grade microbial sequences to enable sequence-based diagnostic assays.

 

 

CROSS-CUTTING TOPICS

Minority Health and Health Equity Women’s Health Maternal Health Pediatric Health
Oncology Rare Diseases One Health Initiative  

 

 

Research Capabilities, Tools, and Resources

Research Management and Collaborations Technology Transfer and Public-Private Partnerships Physical Standards and Reference Materials Intramural Grant Programs Extramural Funding Mechanisms

Scientific Education, Training, and Communication

Fellowship and Training Opportunities Professional Development and Continuing Education Communication and External Meetings

Infrastructure

Facilities and Shared Resources Safety and Compliance

 

ADDITIONAL ORGANIZATIONAL INFORMATION

Office of the Chief Scientist

Office of Regulatory Science and Innovation

Contact Us: FARS@fda.hhs.gov

 

Back to Top